[X] | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
[ ] | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware
(State or other jurisdiction of
incorporation or organization) |
51-0263969
(I.R.S. Employer Identification No.)
|
6901 Professional Pkwy. East, Suite 200
Sarasota, Florida (Address of principal executive offices) |
34240
(Zip Code)
|
(941) 556-2601
(Registrant's telephone number, including area code)
|
þ Large accelerated filer
|
¨ Accelerated filer
|
¨ Non-accelerated filer
(do not check if smaller reporting company)
|
¨ Smaller reporting company
|
|
|
Page
|
PART I.
|
FINANCIAL INFORMATION
|
|
Item 1.
|
Financial Statements (unaudited):
|
|
|
Condensed Consolidated Statements of Earnings
|
3
|
|
Condensed Consolidated Statements of Comprehensive Income
|
4
|
|
Condensed Consolidated Balance Sheets
|
5
|
|
Condensed Consolidated Statements of Cash Flows
|
6
|
|
Condensed Consolidated Statement of Changes in Stockholders' Equity
|
7
|
|
Notes to Condensed Consolidated Financial Statements
|
8
|
Item 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
14
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
20
|
Item 4.
|
Controls and Procedures
|
20
|
PART II.
|
OTHER INFORMATION
|
|
Item 1.
|
Legal Proceedings
|
21
|
Item 1A.
|
Risk Factors
|
21
|
Item 6.
|
Exhibits
|
21
|
|
Signatures
|
22
|
PART I. | FINANCIAL INFORMATION |
|
|
Three months ended
March 31, |
|
||||||
|
|
2013
|
|
|
2012
|
|
|||
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
737,135
|
|
|
$
|
711,066
|
|
|
Cost of sales
|
|
|
315,559
|
|
|
|
319,873
|
|
|
Gross profit
|
|
|
421,576
|
|
|
|
|
391,193
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses
|
|
|
236,399
|
|
|
|
|
220,889
|
|
Income from operations
|
|
|
185,177
|
|
|
|
|
170,304
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net
|
|
|
20,858
|
|
|
|
|
15,483
|
|
Other expense, net
|
|
|
2,492
|
|
|
|
|
490
|
|
|
|
|
|
|
|
|
|
|
|
Earnings before income taxes
|
|
|
161,827
|
|
|
|
|
154,331
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes
|
|
|
36,913
|
|
|
|
|
46,022
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings
|
|
$
|
124,914
|
|
|
|
$
|
108,309
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share:
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
1.26
|
|
|
|
$
|
1.12
|
|
Diluted
|
|
|
1.25
|
|
|
|
|
1.09
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
98,876
|
|
|
|
|
97,039
|
|
Diluted
|
|
|
99,986
|
|
|
|
|
99,307
|
|
|
|
|
|
|
|
|
|
|
|
Dividends declared per common share
|
|
$
|
0.1650
|
|
|
|
$
|
0.1375
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
March 31, |
|
|||||
|
|
2013
|
|
|
2012
|
|
||
|
|
|
|
|
|
|
|
|
Net earnings
|
|
$
|
124,914
|
|
|
$
|
108,309
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income/(loss), net of tax:
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustments
|
|
|
(38,489
|
)
|
|
|
19,161
|
|
|
|
|
|
|
|
|
|
|
Total other comprehensive income/(loss), net of tax
|
|
|
(38,489
|
)
|
|
|
19,161
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income
|
|
$
|
86,425
|
|
|
$
|
127,470
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
2013 |
|
December 31,
2012 |
|
||
ASSETS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
430,022
|
|
$
|
370,590
|
|
Accounts receivable, net
|
|
|
483,861
|
|
|
526,408
|
|
Inventories, net
|
|
|
200,023
|
|
|
190,867
|
|
Deferred taxes
|
|
|
47,372
|
|
|
41,992
|
|
Unbilled receivables
|
|
|
84,948
|
|
|
72,193
|
|
Other current assets
|
|
|
38,830
|
|
|
43,492
|
|
Total current assets
|
|
|
1,285,056
|
|
|
1,245,542
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment, net
|
|
|
110,637
|
|
|
110,397
|
|
Goodwill
|
|
|
3,848,078
|
|
|
3,868,857
|
|
Other intangible assets, net
|
|
|
1,657,893
|
|
|
1,698,867
|
|
Deferred taxes
|
|
|
82,288
|
|
|
78,644
|
|
Other assets
|
|
|
69,038
|
|
|
68,797
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
7,052,990
|
|
$
|
7,071,104
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
138,541
|
|
$
|
138,340
|
|
Accrued compensation
|
|
|
80,043
|
|
|
110,724
|
|
Deferred revenue
|
|
|
190,678
|
|
|
185,912
|
|
Other accrued liabilities
|
|
|
133,403
|
|
|
128,351
|
|
Income taxes payable
|
|
|
15,378
|
|
|
-
|
|
Deferred taxes
|
|
|
8,216
|
|
|
3,868
|
|
Current portion of long-term debt, net
|
|
|
516,514
|
|
|
519,015
|
|
Total current liabilities
|
|
|
1,082,773
|
|
|
1,086,210
|
|
|
|
|
|
|
|
|
|
Long-term debt, net of current portion
|
|
|
1,403,259
|
|
|
1,503,107
|
|
Deferred taxes
|
|
|
701,567
|
|
|
707,278
|
|
Other liabilities
|
|
|
83,215
|
|
|
86,783
|
|
Total liabilities
|
|
|
3,270,814
|
|
|
3,383,378
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
|
1,010
|
|
|
1,006
|
|
Additional paid-in capital
|
|
|
1,182,304
|
|
|
1,158,001
|
|
Retained earnings
|
|
|
2,598,434
|
|
|
2,489,858
|
|
Accumulated other comprehensive earnings
|
|
|
20,048
|
|
|
58,537
|
|
Treasury stock
|
|
|
(19,620
|
)
|
|
(19,676
|
)
|
Total stockholders' equity
|
|
|
3,782,176
|
|
|
3,687,726
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders' equity
|
|
$
|
7,052,990
|
|
$
|
7,071,104
|
|
|
|
Three months ended
March 31, |
|
||||||
|
|
2013
|
|
|
2012
|
|
|||
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|
Net earnings
|
|
$
|
124,914
|
|
|
$
|
108,309
|
|
|
Adjustments to reconcile net earnings to cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization of property, plant and equipment
|
|
|
9,342
|
|
|
|
9,449
|
|
|
Amortization of intangible assets
|
|
|
34,099
|
|
|
|
26,018
|
|
|
Amortization of deferred financing costs
|
|
|
837
|
|
|
|
591
|
|
|
Non-cash stock compensation
|
|
|
12,977
|
|
|
|
9,954
|
|
|
Changes in operating assets and liabilities, net of acquired businesses:
|
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
27,590
|
|
|
|
20,666
|
|
|
Unbilled receivables
|
|
|
(13,136
|
)
|
|
|
(4,698
|
)
|
|
Inventories
|
|
|
(11,687
|
)
|
|
|
(7,462
|
)
|
|
Accounts payable and accrued liabilities
|
|
|
(25,510
|
)
|
|
|
(35,936
|
)
|
|
Income taxes payable
|
|
|
16,348
|
|
|
|
13,720
|
|
|
Other, net
|
|
|
(4,506
|
)
|
|
|
846
|
|
|
Cash provided by operating activities
|
|
|
171,268
|
|
|
|
141,457
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
Acquisitions of businesses, net of cash acquired
|
|
|
(2,240
|
)
|
|
|
(19,007
|
)
|
|
Capital expenditures
|
|
|
(11,205
|
)
|
|
|
(10,008
|
)
|
|
Proceeds from sale of assets
|
|
|
236
|
|
|
|
464
|
|
|
Other, net
|
|
|
(1
|
)
|
|
|
(245
|
)
|
|
Cash used in investing activities
|
|
|
(13,210
|
)
|
|
|
(28,796
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
Payments under revolving line of credit
|
|
|
(100,000
|
)
|
|
|
-
|
|
|
Principal payments on convertible notes
|
|
|
(52
|
)
|
|
|
(6,297
|
)
|
|
Cash premiums paid on convertible note conversions
|
|
|
(109
|
)
|
|
|
(6,576
|
)
|
|
Cash dividends to stockholders
|
|
|
-
|
|
|
|
(13,290
|
)
|
|
Proceeds from stock based compensation, net
|
|
|
6,229
|
|
|
|
16,873
|
|
|
Stock award tax excess windfall benefit
|
|
|
4,364
|
|
|
|
7,505
|
|
|
Treasury stock sales
|
|
|
642
|
|
|
|
600
|
|
|
Other
|
|
|
122
|
|
|
|
(1,089
|
)
|
|
Cash used in financing activities
|
|
|
(88,804
|
)
|
|
|
(2,274
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Effect of foreign currency exchange rate changes on cash
|
|
|
(9,822
|
)
|
|
|
3,230
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase in cash and cash equivalents
|
|
|
59,432
|
|
|
|
113,617
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, beginning of period
|
|
|
370,590
|
|
|
|
338,101
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of period
|
|
$
|
430,022
|
|
|
$
|
451,718
|
|
|
|
Common
stock |
|
Additional paid-in capital
|
|
Retained
earnings
|
|
Accumulated other comprehensive earnings
|
|
Treasury
stock
|
|
Total
|
|
||||||
Balances at December 31, 2012
|
|
$
|
1,006
|
|
$
|
1,158,001
|
|
$
|
2,489,858
|
|
$
|
58,537
|
|
$
|
(19,676
|
)
|
$
|
3,687,726
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings
|
|
|
-
|
|
|
-
|
|
|
124,914
|
|
|
-
|
|
|
-
|
|
|
124,914
|
|
Stock option exercises
|
|
|
2
|
|
|
9,589
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
9,591
|
|
Treasury stock sold
|
|
|
-
|
|
|
587
|
|
|
-
|
|
|
-
|
|
|
56
|
|
|
643
|
|
Currency translation adjustments, net of $1,316 tax
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(38,489
|
)
|
|
-
|
|
|
(38,489
|
)
|
Stock based compensation
|
|
|
-
|
|
|
12,969
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
12,969
|
|
Restricted stock activity
|
|
|
2
|
|
|
(3,349
|
)
|
|
-
|
|
|
-
|
|
|
-
|
|
|
(3,347
|
)
|
Stock option tax benefit, net of shortfalls
|
|
|
-
|
|
|
4,312
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
4,312
|
|
Conversion of senior subordinated convertible notes, net of $304 tax
|
|
|
-
|
|
|
195
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
195
|
|
Dividends declared
|
|
|
-
|
|
|
-
|
|
|
(16,338
|
)
|
|
-
|
|
|
-
|
|
|
(16,338
|
)
|
Balances at March 31, 2013
|
|
$
|
1,010
|
|
$
|
1,182,304
|
|
$
|
2,598,434
|
|
$
|
20,048
|
|
$
|
(19,620
|
)
|
$
|
3,782,176
|
|
1.
|
Basis of Presentation
|
2.
|
Recent Accounting Pronouncements
|
3.
|
Earnings Per Share
|
|
|
Three months ended
March 31,
|
|
||
|
|
2013
|
|
2012
|
|
Basic shares outstanding
|
|
98,876
|
|
97,039
|
|
Effect of potential common stock
|
|
|
|
|
|
Common stock awards
|
|
892
|
|
1,140
|
|
Senior subordinated convertible notes
|
|
218
|
|
1,128
|
|
Diluted shares outstanding
|
|
99,986
|
|
99,307
|
|
4.
|
Stock Based Compensation
|
|
Three months ended
March 31, |
|
|
2013
|
2012
|
Stock based compensation
|
$ 12,977
|
$ 9,954
|
Tax effect recognized in net income
|
4,542
|
3,484
|
Windfall tax benefit, net
|
4,312
|
7,415
|
|
Three months ended March 31,
|
||
|
2013
|
|
2012
|
Fair value per share ($)
|
36.53
|
|
29.65
|
Risk-free interest rate (%)
|
0.80
|
|
0.82
|
Expected option life (years)
|
5.18
|
|
5.22
|
Expected volatility (%)
|
36.29
|
|
36.56
|
Expected dividend yield (%)
|
0.57
|
|
0.59
|
5.
|
Inventories
|
|
|
March 31,
2013 |
|
December 31,
2012 |
|
|||
|
|
(in thousands)
|
|
|||||
Raw materials and supplies
|
|
$
|
125,415
|
|
$
|
121,573
|
|
|
Work in process
|
|
|
31,265
|
|
|
29,725
|
|
|
Finished products
|
|
|
85,929
|
|
|
81,536
|
|
|
Inventory reserves
|
|
|
(42,586
|
)
|
|
(41,967
|
)
|
|
|
|
$
|
200,023
|
|
$
|
190,867
|
|
6.
|
Goodwill and Other Intangible Assets
|
|
|
Industrial Technology
|
|
Energy Systems & Controls
|
|
Medical & Scientific Imaging
|
|
RF Technology
|
|
Total
|
|
|||||
Balances at December 31, 2012
|
|
$
|
421,755
|
|
$
|
404,057
|
|
$
|
1,772,402
|
|
$
|
1,270,643
|
|
$
|
3,868,857
|
|
Other
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
445
|
|
|
445
|
|
Currency translation adjustments
|
|
|
(6,167
|
)
|
|
(2,491
|
)
|
|
(6,136
|
)
|
|
(6,430
|
)
|
|
(21,224
|
)
|
Balances at March 31, 2013
|
|
$
|
415,588
|
|
$
|
401,566
|
|
$
|
1,766,266
|
|
$
|
1,264,658
|
|
$
|
3,848,078
|
|
|
|
Cost
|
|
Accumulated
amortization |
|
Net book
value |
|
|||
Assets subject to amortization:
|
|
|
|
|
|
|
|
|
|
|
Customer related intangibles
|
|
$
|
1,509,339
|
|
$
|
(379,535
|
)
|
$
|
1,129,804
|
|
Unpatented technology
|
|
|
198,609
|
|
|
(97,487
|
)
|
|
101,122
|
|
Software
|
|
|
160,520
|
|
|
(44,256
|
)
|
|
116,264
|
|
Patents and other protective rights
|
|
|
40,399
|
|
|
(20,312
|
)
|
|
20,087
|
|
Trade secrets
|
|
|
1,500
|
|
|
(1,500
|
)
|
|
-
|
|
Assets not subject to amortization:
|
|
|
|
|
|
|
|
|
|
|
Trade names
|
|
|
331,590
|
|
|
-
|
|
|
331,590
|
|
Balances at December 31, 2012
|
|
$
|
2,241,957
|
|
$
|
(543,090
|
)
|
$
|
1,698,867
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets subject to amortization:
|
|
|
|
|
|
|
|
|
|
|
Customer related intangibles
|
|
$
|
1,502,897
|
|
$
|
(400,227
|
)
|
$
|
1,102,670
|
|
Unpatented technology
|
|
|
206,867
|
|
|
(103,202
|
)
|
|
103,665
|
|
Software
|
|
|
160,153
|
|
|
(47,744
|
)
|
|
112,409
|
|
Patents and other protective rights
|
|
|
30,272
|
|
|
(20,894
|
)
|
|
9,378
|
|
Trade secrets
|
|
|
1,500
|
|
|
(1,500
|
)
|
|
-
|
|
Assets not subject to amortization:
|
|
|
|
|
|
|
|
|
|
|
Trade names
|
|
|
329,771
|
|
|
-
|
|
|
329,771
|
|
Balances at March 31, 2013
|
|
$
|
2,231,460
|
|
$
|
(573,567
|
)
|
$
|
1,657,893
|
|
7.
|
Debt
|
8.
|
Fair Value of Financial Instruments
|
$500 million senior notes due 2013
|
$
|
512
|
||
$400 million senior notes due 2017
|
403
|
|||
$500 million senior notes due 2019
|
604
|
|||
$500 million senior notes due 2022
|
498
|
9.
|
Contingencies
|
Balance at December 31, 2012
|
|
$
|
9,755
|
|
Additions charged to costs and expenses
|
|
|
2,624
|
|
Deductions
|
|
|
(2,219
|
)
|
Other
|
|
|
(177
|
)
|
Balance at March 31, 2013
|
|
$
|
9,983
|
|
10.
|
Business Segments
|
|
|
Three months ended March 31,
|
|
|
|
||||
|
|
2013
|
|
2012
|
|
Change
|
|
||
Net sales:
|
|
|
|
|
|
|
|
|
|
Industrial Technology
|
|
$
|
182,239
|
|
$
|
195,136
|
|
(6.6
|
)%
|
Energy Systems & Controls
|
|
|
145,642
|
|
|
148,602
|
|
(2.0
|
)
|
Medical & Scientific Imaging
|
|
|
200,444
|
|
|
162,811
|
|
23.1
|
|
RF Technology
|
|
|
208,810
|
|
|
204,517
|
|
2.1
|
|
Total
|
|
$
|
737,135
|
|
$
|
711,066
|
|
3.7
|
%
|
Gross profit:
|
|
|
|
|
|
|
|
|
|
Industrial Technology
|
|
$
|
93,311
|
|
$
|
98,663
|
|
(5.4
|
)%
|
Energy Systems & Controls
|
|
|
80,906
|
|
|
80,408
|
|
0.6
|
|
Medical & Scientific Imaging
|
|
|
134,869
|
|
|
106,186
|
|
27.0
|
|
RF Technology
|
|
|
112,490
|
|
|
105,936
|
|
6.2
|
|
Total
|
|
$
|
421,576
|
|
$
|
391,193
|
|
7.8
|
%
|
Operating profit*:
|
|
|
|
|
|
|
|
|
|
Industrial Technology
|
|
$
|
52,945
|
|
$
|
57,507
|
|
(7.9
|
)%
|
Energy Systems & Controls
|
|
|
35,722
|
|
|
35,657
|
|
0.2
|
|
Medical & Scientific Imaging
|
|
|
59,928
|
|
|
43,362
|
|
38.2
|
|
RF Technology
|
|
|
56,630
|
|
|
50,353
|
|
12.5
|
|
Total
|
|
$
|
205,225
|
|
$
|
186,879
|
|
9.8
|
%
|
Long-lived assets:
|
|
|
|
|
|
|
|
|
|
Industrial Technology
|
|
$
|
45,626
|
|
$
|
42,698
|
|
6.9
|
%
|
Energy Systems & Controls
|
|
|
19,032
|
|
|
19,439
|
|
(2.2
|
)
|
Medical & Scientific Imaging
|
|
|
40,198
|
|
|
45,602
|
|
(11.8
|
)
|
RF Technology
|
|
|
29,158
|
|
|
29,832
|
|
(2.3
|
)
|
Total
|
|
$
|
134,014
|
|
$
|
137,571
|
|
(2.6
|
)%
|
11.
|
Subsequent Events
|
·
|
general economic conditions;
|
·
|
difficulty making acquisitions and successfully integrating acquired businesses;
|
·
|
any unforeseen liabilities associated with future acquisitions;
|
·
|
limitations on our business imposed by our indebtedness;
|
·
|
unfavorable changes in foreign exchange rates;
|
·
|
difficulties associated with exports;
|
·
|
risks and costs associated with our international sales and operations;
|
·
|
increased directors' and officers' liability and other insurance costs;
|
·
|
risk of rising interest rates;
|
·
|
product liability and insurance risks;
|
·
|
increased warranty exposure;
|
·
|
future competition;
|
·
|
the cyclical nature of some of our markets;
|
·
|
reduction of business with large customers;
|
·
|
risks associated with government contracts;
|
·
|
changes in the supply of, or price for, raw materials, parts and components;
|
·
|
environmental compliance costs and liabilities;
|
·
|
risks and costs associated with asbestos-related litigation;
|
·
|
potential write-offs of our substantial goodwill and other intangible assets;
|
·
|
our ability to successfully develop new products;
|
·
|
failure to protect our intellectual property;
|
·
|
the effect of, or change in, government regulations (including tax);
|
·
|
economic disruption caused by terrorist attacks, health crises or other unforeseen events; and
|
·
|
the factors discussed in other reports filed with the SEC.
|
|
|
Three months ended March 31,
|
|
||||
|
|
2013
|
|
2012
|
|
||
Net sales:
|
|
|
|
|
|
|
|
Industrial Technology
|
|
$
|
182,239
|
|
$
|
195,136
|
|
Energy Systems & Controls
|
|
|
145,642
|
|
|
148,602
|
|
Medical & Scientific Imaging
|
|
|
200,444
|
|
|
162,811
|
|
RF Technology
|
|
|
208,810
|
|
|
204,517
|
|
Total
|
|
$
|
737,135
|
|
$
|
711,066
|
|
Gross profit:
|
|
|
|
|
|
|
|
Industrial Technology
|
|
|
51.2
|
%
|
|
50.6
|
%
|
Energy Systems & Controls
|
|
|
55.6
|
%
|
|
54.1
|
%
|
Medical & Scientific Imaging
|
|
|
67.3
|
%
|
|
65.2
|
%
|
RF Technology
|
|
|
53.9
|
%
|
|
51.8
|
%
|
Total
|
|
|
57.2
|
%
|
|
55.0
|
%
|
Selling, general & administrative expenses:
|
|
|
|
|
|
|
|
Industrial Technology
|
|
|
22.2
|
%
|
|
21.1
|
%
|
Energy Systems & Controls
|
|
|
31.0
|
|
|
30.1
|
|
Medical & Scientific Imaging
|
|
|
37.4
|
|
|
38.6
|
|
RF Technology
|
|
|
26.8
|
|
|
27.2
|
|
Total
|
|
|
29.4
|
|
|
28.7
|
|
Segment operating profit:
|
|
|
|
|
|
|
|
Industrial Technology
|
|
|
29.1
|
%
|
|
29.5
|
%
|
Energy Systems & Controls
|
|
|
24.5
|
|
|
24.0
|
|
Medical & Scientific Imaging
|
|
|
29.9
|
|
|
26.6
|
|
RF Technology
|
|
|
27.1
|
|
|
24.6
|
|
Total
|
|
|
27.8
|
|
|
26.3
|
|
Corporate administrative expenses
|
|
|
(2.7
|
)
|
|
(2.3
|
)
|
|
|
|
25.1
|
|
|
24.0
|
|
Interest expense
|
|
|
(2.8
|
)
|
|
(2.2
|
)
|
Other expense
|
|
|
(0.3
|
)
|
|
(0.1
|
)
|
Earnings before income taxes
|
|
|
22.0
|
|
|
21.7
|
|
Income taxes
|
|
|
(5.0
|
)
|
|
(6.5
|
)
|
Net earnings
|
|
|
16.9
|
%
|
|
15.2
|
%
|
|
|
Net orders booked for the
three months ended
March 31, |
|
Order backlog as of March 31,
|
|
||||||||
|
|
2013
|
|
2012
|
|
2013
|
|
2012
|
|
||||
Industrial Technology
|
|
$
|
179,807
|
|
$
|
204,002
|
|
$
|
126,993
|
|
$
|
152,606
|
|
Energy Systems & Controls
|
|
|
157,537
|
|
|
153,376
|
|
|
120,921
|
|
|
126,262
|
|
Medical & Scientific Imaging
|
|
|
216,121
|
|
|
168,336
|
|
|
247,959
|
|
|
124,681
|
|
RF Technology
|
|
|
240,118
|
|
|
203,672
|
|
|
501,065
|
|
|
447,085
|
|
Total
|
|
$
|
793,583
|
|
$
|
729,386
|
|
$
|
996,938
|
|
$
|
850,634
|
|
|
Three months ended March 31,
|
|||||||
|
2013
|
2012
|
||||||
Cash provided by/(used in):
|
||||||||
Operating activities
|
$
|
171.3
|
$
|
141.5
|
||||
Investing activities
|
(13.2
|
)
|
(28.8
|
)
|
||||
Financing activities
|
(88.8
|
)
|
(2.3
|
)
|
$500 million senior notes due 2013*
|
$
|
502,586
|
||
$400 million senior notes due 2017
|
400,000
|
|||
$500 million senior notes due 2019
|
500,000
|
|||
$500 million senior notes due 2022
|
500,000
|
|||
Senior Subordinated Convertible Notes
|
11,647
|
|||
Revolving Facility
|
-
|
|||
Other
|
5,540
|
|||
Total debt
|
1,919,773
|
|||
Less current portion
|
516,514
|
|||
Long-term debt
|
$
|
1,403,259
|
|
March 31,
2013 |
December 31,
2012
|
||||||
Total Debt
|
$
|
1,919,773
|
$
|
2,022,122
|
||||
Cash
|
(430,022
|
)
|
(370,590
|
)
|
||||
Net Debt
|
1,489,751
|
1,651,532
|
||||||
Stockholders' Equity
|
3,782,176
|
3,687,726
|
||||||
Total Net Capital
|
$
|
5,271,927
|
$
|
5,339,258
|
||||
|
||||||||
Net Debt / Total Net Capital
|
28.3
|
%
|
30.9
|
%
|
31.1
|
Rule 13a-14(a)/15d-14(a), Certification of the Chief Executive Officer, filed herewith.
|
|
|
|
|
31.2
|
Rule 13a-14(a)/15d-14(a), Certification of the Chief Financial Officer, filed herewith.
|
|
|
|
|
32.1
|
Section 1350 Certification of the Chief Executive and Chief Financial Officers, filed herewith.
|
|
|
|
|
101.INS
|
XBRL Instance Document, furnished herewith.
|
|
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document, furnished herewith.
|
|
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document, furnished herewith.
|
|
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document, furnished herewith.
|
|
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document, furnished herewith.
|
|
|
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document, furnished herewith.
|
|
|
|
/s/ Brian D. Jellison
|
|
Chairman of the Board, President,
|
May 9, 2013
|
Brian D. Jellison
|
|
and Chief Executive Officer
|
|
|
|
(Principal Executive Officer)
|
|
/s/ John Humphrey
|
|
Chief Financial Officer and
|
May 9, 2013
|
John Humphrey
|
|
Executive Vice President
|
|
|
|
(Principal Financial Officer)
|
|
/s/ Paul J. Soni
|
|
Vice President and Controller
|
May 9, 2013
|
Paul J. Soni
|
|
(Principal Accounting Officer)
|
|
31.1
|
Rule 13a-14(a)/15d-14(a), Certification of the Chief Executive Officer, filed herewith.
|
|
|
|
|
31.2
|
Rule 13a-14(a)/15d-14(a), Certification of the Chief Financial Officer, filed herewith.
|
|
|
|
|
32.1
|
Section 1350 Certification of the Chief Executive and Chief Financial Officers, filed herewith.
|
|
|
|
|
101.INS
|
XBRL Instance Document, furnished herewith.
|
|
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document, furnished herewith.
|
|
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document, furnished herewith.
|
|
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document, furnished herewith.
|
|
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document, furnished herewith.
|
|
|
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document, furnished herewith.
|
|
|
|
|
|
|